 SANTA MONICA, Calif., Aug. 01, 2022 GLOBE NEWSWIRE -- Opiant Pharmaceuticals, Inc. Opiant or Company NASDAQ: OPNT, a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced it will report its financial results for the second quarter ended June 30, 2022, after the financial markets close on Thursday, August 11, 2022. 